HUP0303928A2 - Omeprazol kristályos formája, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények - Google Patents

Omeprazol kristályos formája, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények

Info

Publication number
HUP0303928A2
HUP0303928A2 HU0303928A HUP0303928A HUP0303928A2 HU P0303928 A2 HUP0303928 A2 HU P0303928A2 HU 0303928 A HU0303928 A HU 0303928A HU P0303928 A HUP0303928 A HU P0303928A HU P0303928 A2 HUP0303928 A2 HU P0303928A2
Authority
HU
Hungary
Prior art keywords
omeprazole
crystalline form
preparation
pharmaceutical compositions
compositions containing
Prior art date
Application number
HU0303928A
Other languages
English (en)
Inventor
Beléié Andreja Cizerle
Milaé Natasa Hafner
Alenka Kosak
Brina Ornik
Barbara Podobnik
Uros Urleb
Anton Éopar
Original Assignee
Lek Pharmaceutical And Chemical Company D.D.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=20432882&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUP0303928(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lek Pharmaceutical And Chemical Company D.D. filed Critical Lek Pharmaceutical And Chemical Company D.D.
Publication of HUP0303928A2 publication Critical patent/HUP0303928A2/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

A találmány az 5-metoxi-2-[/(4-metoxi-3,5-dimetil-2-piridinil)-metil/-szulfinil]-1H-benzimidazol kémiai néven, illetve omeprazol generikusnéven ismert vegyület új kristályos formájára, azaz az omeprazol Cformára vonatkozik. A találmány tárgya továbbá az omeprazol C formaelőállítására szolgáló eljárás, egy hatóanyagként omeprazol C formátgyógyászatilag elfogadható segédanyaggal együtt tartalmazógyógyszerkészítmény, valamint az omeprazol C forma alkalmazása gyomor-bél rendszeri betegségek kezelésére. Ó
HU0303928A 2001-04-25 2002-04-24 Omeprazol kristályos formája, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények HUP0303928A2 (hu)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SI200100111A SI20875A (sl) 2001-04-25 2001-04-25 Kristalna oblika omeprazola
PCT/IB2002/001350 WO2002085889A1 (en) 2001-04-25 2002-04-24 Crystalline form of omeprazole

Publications (1)

Publication Number Publication Date
HUP0303928A2 true HUP0303928A2 (hu) 2004-03-01

Family

ID=20432882

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0303928A HUP0303928A2 (hu) 2001-04-25 2002-04-24 Omeprazol kristályos formája, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények

Country Status (26)

Country Link
US (2) US20040122056A1 (hu)
EP (1) EP1390360B1 (hu)
JP (1) JP4455815B2 (hu)
KR (1) KR20030094358A (hu)
CN (1) CN1531533B (hu)
AT (1) ATE346063T1 (hu)
AU (1) AU2002307892B2 (hu)
BG (1) BG108287A (hu)
BR (1) BR0209103A (hu)
CA (1) CA2445251C (hu)
CZ (1) CZ20032911A3 (hu)
DE (1) DE60216273T2 (hu)
HR (1) HRP20030853B1 (hu)
HU (1) HUP0303928A2 (hu)
IL (1) IL158561A0 (hu)
MX (1) MXPA03009789A (hu)
NO (1) NO20034715L (hu)
NZ (1) NZ528917A (hu)
PL (1) PL366471A1 (hu)
RS (1) RS50880B (hu)
RU (1) RU2286991C2 (hu)
SI (2) SI20875A (hu)
SK (1) SK13192003A3 (hu)
UA (1) UA77671C2 (hu)
WO (1) WO2002085889A1 (hu)
ZA (1) ZA200307988B (hu)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8815916B2 (en) 2004-05-25 2014-08-26 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
ES2246149B1 (es) * 2004-07-02 2007-06-01 Esteve Quimica, S.A. Formas solidas de la sal magnesica de s-omeprazol y procedimientos para su preparacion.
EP1904064A4 (en) * 2005-07-07 2009-12-02 Reddys Lab Ltd Dr OMEPRAZOLE OF FORM B
EP1988163B1 (en) * 2006-02-22 2012-06-27 International Institute of Cancer Immunology, Inc. Hla-a*3303-restricted wt1 peptide and pharmaceutical composition comprising the same
WO2008067037A2 (en) 2006-10-05 2008-06-05 Santarus, Inc. Novel formulations of proton pump inhibitors and methods of using these formulations
EP2086543A2 (en) 2006-10-27 2009-08-12 The Curators of the University of Missouri Compositions comprising at least one acid labile proton pump inhibiting agents, optionally other pharmaceutically active agents and methods of using same
WO2008092939A2 (en) 2007-01-31 2008-08-07 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of optically pure omeprazole via salt formation with a chiral amine or treatment with an entiomer converting enzyme and chromatographic separation
WO2010134099A1 (en) 2009-05-21 2010-11-25 Cadila Healthcare Limited One pot process for preparing omeprazole and related compounds
CN102786513A (zh) * 2011-05-18 2012-11-21 中国医学科学院药物研究所 奥美拉唑晶e型物质及制备方法与在药品和保健品中应用
CN102351846B (zh) * 2011-09-07 2012-08-22 周晓东 一种新的奥美拉唑钠化合物及其药物组合物
KR101459088B1 (ko) * 2012-08-02 2014-12-02 대화제약 주식회사 알-라베프라졸, 이의 금속염의 제조방법
WO2023079094A1 (en) * 2021-11-05 2023-05-11 Cinclus Pharma Holding AB (publ) Polymorphs of the hydrochloride salt of linaprazan glurate
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
IE67187B1 (en) * 1990-06-15 1996-03-06 Merck & Co Inc A crystallization method to improve crystal structure and size
SE510666C2 (sv) * 1996-12-20 1999-06-14 Astra Ab Nya Kristallmodifikationer
SI20019A (sl) * 1998-07-13 2000-02-29 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Izboljšan postopek sinteze 5-metoksi -2-/(4-metoksi-3,5-dimetil-2-piridil)metil/ sulfinil-1H-benzimidazola
US6166213A (en) * 1998-08-11 2000-12-26 Merck & Co., Inc. Omeprazole process and compositions thereof
UA72748C2 (en) * 1998-11-10 2005-04-15 Astrazeneca Ab A novel crystalline form of omeprazole
AUPQ841800A0 (en) * 2000-06-28 2000-07-20 Biomolecular Research Institute Limited Truncated egf receptor
US6627646B2 (en) * 2001-07-17 2003-09-30 Sepracor Inc. Norastemizole polymorphs

Also Published As

Publication number Publication date
BR0209103A (pt) 2004-07-13
UA77671C2 (en) 2007-01-15
SI1390360T1 (sl) 2007-04-30
CA2445251C (en) 2011-01-04
CN1531533B (zh) 2012-07-18
SI20875A (sl) 2002-10-31
JP2004526786A (ja) 2004-09-02
AU2002307892B2 (en) 2008-04-17
EP1390360A1 (en) 2004-02-25
US20060079560A1 (en) 2006-04-13
EP1390360B1 (en) 2006-11-22
PL366471A1 (en) 2005-02-07
DE60216273T2 (de) 2007-05-31
BG108287A (bg) 2005-04-30
RU2003133213A (ru) 2005-05-10
ZA200307988B (en) 2004-10-14
US20040122056A1 (en) 2004-06-24
KR20030094358A (ko) 2003-12-11
IL158561A0 (en) 2004-05-12
SK13192003A3 (sk) 2004-03-02
CA2445251A1 (en) 2002-10-31
JP4455815B2 (ja) 2010-04-21
HRP20030853B1 (en) 2011-11-30
ATE346063T1 (de) 2006-12-15
MXPA03009789A (es) 2005-03-07
NO20034715D0 (no) 2003-10-21
HRP20030853A2 (en) 2005-08-31
US7553856B2 (en) 2009-06-30
DE60216273D1 (de) 2007-01-04
NZ528917A (en) 2006-02-24
NO20034715L (no) 2003-12-10
WO2002085889A1 (en) 2002-10-31
CZ20032911A3 (en) 2004-06-16
RS50880B (sr) 2010-08-31
CN1531533A (zh) 2004-09-22
YU84003A (sh) 2006-08-17
RU2286991C2 (ru) 2006-11-10

Similar Documents

Publication Publication Date Title
HUP0303928A2 (hu) Omeprazol kristályos formája, eljárás az előállítására és ezt tartalmazó gyógyszerkészítmények
WO1999008500A3 (en) New crystalline form of omeprazole
ES2191944T3 (es) Forma cristalina de la sal de sodio de omeprazol.
SE9900274D0 (sv) New compound
DE60317562D1 (de) Benzofuranderivate,verfahren zu deren herstellung und zwischenprodukte davon
HK1070886A1 (en) Alkylammonium salts of omeprazole and esomeprazole
JP2002535401A5 (hu)
SE0302382D0 (sv) New salts II
HUP0300006A2 (en) 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline mesylat and polymorphs, process for their preparation and pharmaceutical compositions containing them
SE0302381D0 (sv) New salts I
MXPA05009183A (es) Polimorfos de s-omeprazol.
JP2007504222A5 (hu)
YU32301A (sh) Novi kristalni oblik omeprazola
MY118724A (en) New crystalline form of omeprazole

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees